Lloyd's reported a 6.7% market-wide reduction in risk-adjusted rates in its first-half 2026 release. That is a market signal, not proof that every class is underpriced. Actuarial analysis must identify where the reduction sits, whether exposure quality changed and whether loss-cost inflation has been fully reflected.
Rate change is not the same as premium change
Premium can grow while price adequacy falls. A book may write more exposure, add new syndicates or change limits while achieving lower risk-adjusted rate per unit. The correct comparison is on a like-for-like exposure basis, with claims trend, attachment points, limits, deductibles and terms normalised.
A practical adequacy framework
Start with an indicated technical price by segment. Add claims inflation, social inflation where relevant, exposure trend and changes in policy wording. Then compare the indication with achieved price at the level where the risk is actually selected. A market average can be a useful benchmark, but it cannot replace an account-level adequacy test.
For long-tail classes, the analysis also needs a cash-flow view. A lower rate today can appear attractive if the first-year loss ratio is benign but become expensive once late claims inflation and reserve uncertainty are included. Discounted and undiscounted views should be reconciled rather than treated as competing answers.
Governance for a softening market
Pricing committees should define escalation triggers before the soft market accelerates: minimum technical margin, maximum deviation from indication, concentration limits and documentation requirements for exceptions. The board should see both growth and adequacy, not growth alone.
Quantica Risk Modelling uses this separation to keep commercial ambition visible without losing the actuarial control environment. Source: Lloyd's public results release.